Exodus Point Capital Management, LP Madrigal Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 2,645 shares of MDGL stock, worth $825,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,645Holding current value
$825,240% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding MDGL
# of Institutions
297Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$773 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$637 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$633 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$622 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$616 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.34B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...